Injections of Clostridium botulinum neurotoxin A may cause thyroid complications in predisposed persons based on molecular mimicry with thyroid autoantigens
- 217 Downloads
- 13 Citations
Abstract
A woman with Hashimoto’s thyroiditis, under replacement L-T4, repeatedly experienced, over a 10-year period, elevations of serum TSH after eyelid injections of Clostridium botulinum neurotoxin A (Btx). We hypothesized a link between Btx injections and TSH elevations via molecular mimicry, and aimed to verify our hypothesis. Using an in silico approach, we searched first for amino acid sequence homology between Btx and thyroid autoantigens, and next for HLA binding motifs within homologous segments. We found that (i) Btx and thyroid autoantigens share amino acid sequence homology; (ii) some homologous regions contain epitopes of both Btx and thyroid autoantigens; (iii) some of such regions contain HLA-DR3 and/or HLA-DR7 binding motifs, which predominate over other HLA-DRs. This is relevant because the patient’s HLA-DR haplotype was DR3/DR7. In conclusion, clinical and bioinformatics data suggest a possible pathogenetic link between Btx and autoimmune thyroid diseases. Considering the wide and increasing medical and dermocosmetic use of Btx, and the frequently subclinical course of autoimmune thyroid diseases, we think that thyroid “complications” may pass frequently undetected in Btx-treated persons.
Keywords
Clostridium botulinum neurotoxin A Autoimmune thyroid diseases Thyrotropin Molecular mimicry Amino acid sequence homologyReferences
- 1.R. Hackett, P.C. Kam, Med. Chem. 3, 333–345 (2007)CrossRefPubMedGoogle Scholar
- 2.American Society for Aesthetic Plastic Surgery, News release on Statistics, Surveys and Trends in Aesthetic Medicine in 2009. http://www.surgery.org/media/news-releases/despite-recession-overall-plastic-surgery-demand-drops-only-2-percent-from-last-year (checked September 17, 2010) (2010)
- 3.S. Benvenga, L. Bartolone, M.A. Pappalardo, A. Russo, D. Lapa, G. Giorgianni, G. Saraceno, F. Trimarchi, Thyroid 18, 293–301 (2008)CrossRefPubMedGoogle Scholar
- 4.S. Benvenga, L. Santarpia, F. Trimarchi, F. Guarneri, Thyroid 16, 225–236 (2006)CrossRefPubMedGoogle Scholar
- 5.F. Guarneri, S. Benvenga, Curr. Opin. Endocrinol. Diabetes Obes. 14, 398–409 (2007)CrossRefPubMedGoogle Scholar
- 6.National Institute of Health Transplantation and Immunology Branch Staff, in Manual of tissue typing techniques, DHEW publication no. 80-545, ed. by T. Ray (National Institute of Health, Bethesda, 1979)Google Scholar
- 7.B.Peters, J.Sidney, P.Bourne, H.H.Bui, S.Buus, G.Doh, W.Fleri, M.Kronenberg, R.Kubo, O.Lund, D.Nemazee, J.V.Ponomarenko, M.Sathiamurthy, S.Schoenberger, S.Stewart, P.Surko, S.Way, S.Wilson, A.Sette, PLoS Biol. 3, e91 (2005) Database freely available at http://www.immuneepitope.org, accessed on 28 October 2009
- 8.C.A. Naranjo, U. Busto, E.M. Sellers, P. Sandor, I. Ruiz, E.A. Roberts, E. Janecek, C. Domecq, D.J. Greenblatt, Clin. Pharmacol. Ther. 30, 239–245 (1981)CrossRefPubMedGoogle Scholar
- 9.European Medicines Agency 2003 Referral on Botox – Annex III. Available at http://www.ema.europa.eu/pdfs/human/referral/botox/426003en.pdf, accessed on May 1, 2010
- 10.D. Dressler, Nervenarzt 79(Suppl 1), 36–40 (2008)PubMedGoogle Scholar
- 11.H. Göschel, K. Wohlfarth, J. Frevert, R. Dengler, H. Bigalke, Exp. Neurol. 147, 96–102 (1997)CrossRefPubMedGoogle Scholar
- 12.Z. Kraiem, B.Y. Cho, O. Sadeh, M.H. Shong, P. Pickerill, A.P. Weetman, Clin. Endocrinol. (Oxf) 37, 135–140 (1992)CrossRefGoogle Scholar
- 13.S.B. Feingold, J. Smith, J. Houtz, E. Popovsky, R.S. Brown, J. Clin. Endocrinol. Metab. 94, 4742–4748 (2009)CrossRefPubMedGoogle Scholar
- 14.S. Refetoff, J. Endocrinol. Invest. 26, 770–779 (2003)PubMedGoogle Scholar
- 15.S. Refetoff, J. Chin. Med. Assoc. 66, 441–452 (2003)PubMedGoogle Scholar
- 16.A. Nicoletti, M. Bal, G. De Marco, L. Baldazzi, P. Agretti, S. Menabò, E. Ballarini, A. Cicognani, M. Tonacchera, A. Cassio, J. Clin. Endocrinol. Metab. 94, 4187–4194 (2009)CrossRefPubMedGoogle Scholar
- 17.M.F. Prummel, L.J. Brokken, W.M. Wiersinga, Thyroid 14, 825–829 (2004)CrossRefPubMedGoogle Scholar
- 18.P. Crisanti, B. Omri, E. Hughes, G. Meduri, C. Hery, E. Clauser, C. Jacquemin, B. Saunier, Endocrinology 142, 812–822 (2001)CrossRefPubMedGoogle Scholar
- 19.J. Bockmann, C. Winter, W. Wittkowski, M.R. Kreutz, T.M. Bockers, Biochem. Biophys. Res. Commun. 238, 173–178 (1997)CrossRefPubMedGoogle Scholar
- 20.R. Hall, S.G. Owen, Br. Med. J. 2, 710–711 (1960)CrossRefPubMedGoogle Scholar
- 21.S.M. McLachlan, B. Rapoport, in Werner & Ingbar’s the thyroid: a fundamental and clinical text, 8th edn., ed. by L.E. Braverman, R.D. Utiger (Lippincott Williams & Wilkins, Philadelphia, 2000)Google Scholar
- 22.Y. Ban, Y. Tomer, Clin. Dev. Immunol. 12, 47–58 (2005)CrossRefPubMedGoogle Scholar
- 23.Y. Tomer, A. Huber, J. Autoimmun. 32, 231–239 (2009)CrossRefPubMedGoogle Scholar
- 24.E.M. Jacobson, A. Huber, Y. Tomer, J. Autoimmun. 30, 58–62 (2008)CrossRefPubMedGoogle Scholar
- 25.M. Dittmar, G.J. Kahaly, Thyroid 15, 239–250 (2005)CrossRefPubMedGoogle Scholar
- 26.L.D. Kohn, N. Harii, Autoimmunity 36, 331–337 (2003)CrossRefPubMedGoogle Scholar
- 27.B.R. Smith, J. Sanders, J. Furmaniak, Thyroid 17, 923–938 (2007)CrossRefPubMedGoogle Scholar
- 28.P. Perros, A.J. Dickinson, in Werner & Ingbar’s the thyroid: a fundamental and clinical text, 8th edn., ed. by L.E. Braverman, R.D. Utiger (Lippincott Williams & Wilkins, Philadelphia, 2005)Google Scholar
- 29.A.R. Harrison, J.P. Erickson, Ophthal. Plast. Reconstr. Surg. 22, 397–398 (2006)CrossRefPubMedGoogle Scholar
- 30.S.F.Altschul, T.L.Madden, A.A.Schäffer, J.Zhang, Z.Zhang, W.Miller, D.J.Lipman, Nucleic Acids Res. 25, 3389–3402 (1997) (software freely available at http://blast.ncbi.nlm.nih.gov/Blast.cgi, accessed on 28 February 2009)
- 31.M. Sathiamurthy, H.D. Hickman, J.W. Cavett, A. Zahoor, K. Prilliman, S. Metcalf, M. Fernandez Vina, W.H. Hildebrand, Tissue Antigens 61, 12–19 (2003)CrossRefPubMedGoogle Scholar